Skip to main content
. Author manuscript; available in PMC: 2018 Mar 22.
Published in final edited form as: Eval Program Plann. 2017 Feb 7;62:73–80. doi: 10.1016/j.evalprogplan.2017.02.007

Table A1.

Mean, Median, and in-Kind Cost for Program Activities by Screening Tests.

Colonoscopy Programs FOBT/FIT-based Programs.


Mean (Median) of Years 1–3 % in-kind costs Mean (Median) of Years 1–3 % in-kind costs
Clinical Services Related Activities
Screening and diagnosis costs $754,228 (700,213) 18% $405,791 (252,358) 23%
Surveillance (only programs with surveillance) $76,745 (63,309) 0% $34,726 (41,371) 8%
Direct Non-Clinical Screening Provision Activities
Manage provider contracts, billing systems and other procedures $46,625 (46,250) 5% $76,495 (68,824) 4%
Provide patient navigation and support services $97,393 (35,061) 14% $54,747 (49,290) 1%
Provide support to providers for screening and diagnostic services $60,079 (9708) 36% $11,159 (1315) 0%
Ensure appropriate treatment for complications and cancers $41,026 (21,118) 2% $15,893 (13,493) 16%
Other screening provision activities $22,305 (2667) 6% $9,945 (1276) 1%
Indirect Non-Clinical Overarching Activities
Program management $142,231 (123,403) 18% $275,863 (129,547) 9%
Quality assurance and professional development $35,149 (27,326) 6% $90,760 (39,158) 52%
Partnership development and maintenance $21,663 (17,407) 6% $26,607 (20,924) 0%
Data collection and tracking $105,079 (75,265) 2% $97,063 (83,968) 4%
Program monitoring and evaluation $44,281 (36,684) 2% $54,836 (26,214) 14%
Other activities $11,146 (1141) 62% $23,571 (5340) 4%
Administration $82,001 (44,574) 15% $80,793 (82,662) 0%

FOBT fecal occult blood test; FIT fecal immunochemical test. Note: Other activities include costs that could not be separated into specific activities.